Comparison of percutaneous coronary intervention with coronary artery bypass grafting in unprotected left main coronary artery disease – 5-year outcome from CREDO-Kyoto PCI/CABG registry cohort-2 –

Circulation Journal

Volumn 79, Issue 6, 2015, Pages 1281-1289

  Shiomi, Hiroki ^a   Morimoto, Takeshi ^b   Furukawa, Yutaka ^c   Nakagawa, Yoshihisa ^d   Sakata, Ryuzo ^a   Okabayashi, Hitoshi ^e   Hanyu, Michiya ^f   Shimamoto, Mitsuomi ^g   Nishiwaki, Noboru ^h   Komiya, Tatsuhiko ⁱ   Kimura, Takeshi ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^d TENRI HOSPITAL   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f KOKURA MEMORIAL HOSPITAL   (Japan)

^g SHIZUOKA CITY SHIMIZU HOSPITAL   (Japan)

^h KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

ⁱ KURASHIKI CENTRAL HOSPITAL   (Japan)

Author keywords

Coronary artery bypass grafting; Drug eluting stents; Left main disease; Percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; NITRIC ACID DERIVATIVE; PROTON PUMP INHIBITOR; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; WARFARIN; ANTITHROMBOCYTIC AGENT; CARDIOVASCULAR AGENT;

AGED; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEATH; DRUG ELUTING CARDIOVASCULAR STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OFF PUMP CORONARY SURGERY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; SYNTAX SCORE; UNPROTECTED LEFT MAIN CORONARY ARTERY DISEASE; ADVERSE EFFECTS; CAUSE OF DEATH; COMORBIDITY; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; JAPAN; KAPLAN MEIER METHOD; MORTALITY; MULTIMODALITY CANCER THERAPY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; STENT; STROKE; TREATMENT OUTCOME;

CARDIOVASCULAR AGENTS; CAUSE OF DEATH; COMBINED MODALITY THERAPY; COMORBIDITY; CORONARY ARTERY BYPASS; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; FOLLOW-UP STUDIES; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MORTALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK; SEVERITY OF ILLNESS INDEX; STENTS; STROKE; TREATMENT OUTCOME;

EID: 84930079150     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0034     Document Type: Article

References (23)

1. Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med 2009; 360: 961 – 972.
2. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxeleluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. Circulation 2010; 121: 2645 – 2653.
3. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008; 358: 1781 – 1792.
4. Park SJ, Kim YH, Park DW, Yun SC, Ahn JM, Song HG, et al. Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med 2011; 364: 1718 – 1727.
5. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011; 124: e574 – e651, doi:10.1161/CIR.0b013e31823ba622.
6. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC), the European Association for Cardio-Thoracic Surgery (EACTS), European Association for Percutaneous Cardiovascular Interventions (EAPCI), Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, et al. Guidelines on myocardial revascularization. Eur Heart J 2010; 31: 2501 – 2555.
7. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541 – 2619.
8. Shiomi H, Tamura T, Niki S, Tada T, Tazaki J, Toma M, et al. Interand intra-observer variability for assessment of the synergy between percutaneous coronary intervention with TAXUS and Cardiac surgery (SYNTAX) score and association of the SYNTAX score with clinical outcome in patients undergoing unprotected left main stenting in the real world. Circ J 2011; 75: 1130 – 1137.
9. Kimura T, Morimoto T, Nakagawa Y, Kawai K, Miyazaki S, Muramatsu T, et al. Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: Five-year outcome of the j-Cypher Registry. Circulation 2012; 125: 584 – 591.
10. Nakagawa Y, Kimura T, Morimoto T, Nomura M, Saku K, Haruta S, et al. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry). Am J Cardiol 2010; 106: 329 – 336.
11. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, et al. Late adverse events after implantation of sirolimuseluting stent and bare-metal stent: Long-term (5–7 years) follow-up of the coronary revascularization demonstrating outcome study-kyoto registry cohort-2. Circ Cardiovasc Interv 2014; 7: 168 – 179.
12. Chieffo A, Magni V, Latib A, Maisano F, Ielasi A, Montorfano M, et al. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions: The Milan experience. JACC Cardiovasc Interv 2010; 3: 595 – 601.
13. Morice MC, Serruys PW, Kappetein AP, Feldman TE, Stahle E, Colombo A, et al. Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the SYNTAX trial. Circulation 2014; 129: 2388 – 2394.
14. Park DW, Kim YH, Yun SC, Lee JY, Kim WJ, Kang SJ, et al. Longterm outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry. J Am Coll Cardiol 2010; 56: 1366 – 1375.
15. Park DW, Seung KB, Kim YH, Lee JY, Kim WJ, Kang SJ, et al. Long-term safety and efficacy of stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 5-year results from the MAIN-COMPARE (Revascularization for Unprotected Left Main Coronary Artery Stenosis: Comparison of Percutaneous Coronary Angioplasty Versus Surgical Revascularization) registry. J Am Coll Cardiol 2010; 56: 117 – 124.
16. Shiomi H, Morimoto T, Hayano M, Furukawa Y, Nakagawa Y, Tazaki J, et al. Comparison of long-term outcome after percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease (from the CREDO-Kyoto PCI/CABG Registry Cohort-2). Am J Cardiol 2012; 110: 924 – 932.
17. Kimura T, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, et al. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc Interv Ther 2011; 26: 234 – 245.
18. Campos CM, van Klaveren D, Iqbal J, Onuma Y, Zhang YJ, Garcia Garcia HM, et al. Predictive performance of SYNTAX score II in patients with left main and multivessel coronary artery disease: Analysis of CREDO-Kyoto registry. Circ J 2014; 78: 1942 – 1949.
19. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001; 344: 1117 – 1124.
20. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction: The GUSTO investigators. N Engl J Med 1993; 329: 673 – 682.
21. Tazaki J, Shiomi H, Morimoto T, Imai M, Yamaji K, Sakata R, et al. Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: Observations from the CREDO-Kyoto PCI/CABG registry cohort-2. EuroIntervention 2013; 9: 437 – 445.
22. Nishino T, Furukawa Y, Kaji S, Ehara N, Shiomi H, Kim K, et al. Distinct survival benefits of angiotensin-converting enzyme inhibitors/ angiotensin II receptor blockers in revascularized coronary artery disease patients according to history of myocardial infarction. Circ J 2013; 77: 1242 – 1252.
23. Fortuna D, Nicolini F, Guastaroba P, De Palma R, Di Bartolomeo S, Saia F, et al. Coronary artery bypass grafting vs percutaneous coronary intervention in a ‘real-world’ setting: A comparative effectiveness study based on propensity score-matched cohorts. Eur J Cardiothorac Surg 2013; 44: e16 – e24, doi:10.1093/ejcts/ezt197.